Search Results for 'sinuva'
-
Sinuva Approved by CMS for Reimbursement
An alternative treatment option for patients with recurrent polyps who have had prior sinus surgery.Business Wire 06.09.20
-
Intersect ENT Touts Publication of a Pooled Analysis of the SINUVA Sinus Implant for Nasal Polyps
Pooled analysis of the RESOLVE and RESOLVE II studies provides Level 1a clinical evidence.Business Wire 07.23.19
-
Intersect ENT Announces Executive Team Appointments
Company hires chief operations officer and names chief strategy officer.Business Wire 12.12.18
-
Intersect ENT Launches SINUVA Sinus Implant
New treatment is clinically proven to reduce polyps and symptoms of nasal congestion.Business Wire 05.03.18
-
Study Shows Intersect ENT's SINUVA Significantly Reduces Nasal Obstruction, Improves Sense of Smell
SINUVA expands in the sinus cavity and delivers an anti-inflammatory steroid directly to the site of polyp disease.Business Wire 02.13.18
-
FDA Approves Intersect ENT's SINUVA Sinus Implant
Product offers targeted relief for managing recurrent nasal polyps.Business Wire 01.12.18
